BiotechTube
Home/Prota Therapeutics/Dr. Paul Kelly
DP

Dr. Paul Kelly

Director, OneVentures

Prota Therapeutics

Therapeutic Areas

Immunology

Prota Therapeutics Pipeline

DrugIndicationPhase
PRT120Peanut allergyPhase 3

Leadership Team at Prota Therapeutics

PM
Prof. Mimi Tang
Founding CEO & Scientific Founder
DM
Dr. Mark Hasleton
Acting CEO
CJ
Cameron Jones
Chief Financial Officer
PM
Patrick Machado
Chair, Board of Directors
AD
Adam Deutsch
Director, SPRIM Global Investments
View full Prota Therapeutics profile